These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19483127)

  • 1. Vaccine adherence in adolescents.
    Lehmann C; Benson PA
    Clin Pediatr (Phila); 2009 Oct; 48(8):801-11. PubMed ID: 19483127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine schedules and procedures, 2007.
    Middleton DB; Zimmerman RK; Mitchell KB
    J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S47-60, C4-8. PubMed ID: 17270110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National vaccination coverage among adolescents aged 13-17 years--United States, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Aug; 56(34):885-8. PubMed ID: 17728694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent vaccination: coverage achieved by ages 13-15 years, and vaccinations received as recommended during ages 11-12 years, National Health Interview Survey 1997-2003.
    McCauley MM; Stokley S; Stevenson J; Fishbein DB
    J Adolesc Health; 2008 Dec; 43(6):540-7. PubMed ID: 19027641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New adolescent vaccination recommendations and how to make them "stick".
    Middleman AB
    Curr Opin Pediatr; 2007 Aug; 19(4):411-6. PubMed ID: 17630604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination coverage among adolescents aged 13-17 years - United States, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(40):1100-3. PubMed ID: 18846032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
    Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
    Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
    Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
    Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of adolescents.
    Averhoff FM; Williams WW; Hadler SC
    Am Fam Physician; 1997 Jan; 55(1):159-67. PubMed ID: 9012275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization update: pertussis, meningoccocus, and human papillomavirus.
    Middleman AB
    Adolesc Med Clin; 2006 Oct; 17(3):547-63; abstract ix-x. PubMed ID: 17030279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescent consent for vaccination: a position paper of the Society for Adolescent Health and Medicine.
    ; English A; Ford CA; Kahn JA; Kharbanda EO; Middleman AB
    J Adolesc Health; 2013 Oct; 53(4):550-3. PubMed ID: 24054082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):997-1001. PubMed ID: 19763075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
    Wilson TR
    J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Dylag AM; Shah SI
    Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium.
    Theeten H; Vandermeulen C; Roelants M; Hoppenbrouwers K; Depoorter AM; Van Damme P
    Acta Paediatr; 2009 Aug; 98(8):1307-12. PubMed ID: 19432835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How effectively can health care settings beyond the traditional medical home provide vaccines to adolescents?
    Schaffer SJ; Fontanesi J; Rickert D; Grabenstein JD; Rothholz MC; Wang SA; Fishbein D;
    Pediatrics; 2008 Jan; 121 Suppl 1():S35-45. PubMed ID: 18174319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who's calling the shots? Pediatricians' adherence to the 2001-2003 pneumococcal conjugate vaccine-shortage recommendations.
    Broder KR; MacNeil A; Malone S; Schwartz B; Baughman AL; Murphy TV; Pickering LK; Moran JS
    Pediatrics; 2005 Jun; 115(6):1479-87. PubMed ID: 15930207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for use of Tdap booster vaccines for adolescent immunization: overview of efficacy, safety, and clinical use.
    Hitchcock WP
    Clin Pediatr (Phila); 2006 Nov; 45(9):785-94. PubMed ID: 17041165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.